SCHEMBL15975291

SCHEMBL15975291

CN(Cc1ccc(Br)cc1)Sc1ccccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PYCR1 P32322 9/20 0.41
▸ MAOB P27338 1/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ HPGD P15428 1/20 0.40
▸ HTT P42858 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ GAA P10253 1/20 0.38
▸ PRMT3 O60678 1/20 0.38
▸ CARM1 Q86X55 1/20 0.38
▸ PRMT6 Q96LA8 1/20 0.38
▸ PRMT8 Q9NR22 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ PRMT1 Q99873 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9475092 0.65 SMN1; SMN2 (0.50) MAOBL3MBTL1LMNASMN1; SMN2HPGD
SCHEMBL15128047 0.65 PYCR1 (0.67) PYCR1MAOBL3MBTL1LMNATP53
SCHEMBL399795 0.65 HRH3 (0.64) PYCR1MAOBL3MBTL1SMN1; SMN2HTT
SCHEMBL11351060 0.65 TSHR (0.47) PYCR1MAOBLMNASMN1; SMN2TSHR
SCHEMBL19700321 0.62 PYCR1 (0.55) PYCR1MAOBL3MBTL1HTTTSHR
SCHEMBL18598042 0.62 AOC3 (0.60) PYCR1MAOBL3MBTL1HTTTSHR
SCHEMBL31319077 0.61 TP53 (0.43) LMNATP53HPGDTSHRGAA
SCHEMBL12844706 0.61 HDAC1 (0.48) PYCR1MAOBL3MBTL1HTTTSHR
SCHEMBL1241075 0.60 KDM4E (0.69) PYCR1MAOBSMN1; SMN2HTTKDM4E
SCHEMBL10517000 0.60 TSHR (0.56) PYCR1MAOBLMNASMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8815935-B2 Inhibitors of protein prenyltransferases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-08-26 — — US disclosed
US-20130102639-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-04-25 — — US disclosed
US-20110178138-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-07-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130102639-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES RABGGTA, FNTA, RABGGTB PYCR1 2760/4885MAOB 4465/4885L3MBTL1 1203/4885
US-20110178138-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES RABGGTA, FNTA, RABGGTB PYCR1 2760/4885MAOB 4465/4885L3MBTL1 1203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback